Blockade of TMEM16A protects against renal fibrosis by reducing intracellular Cl - concentration.

Xiao-Long LiJing LiuXiao-Shan ChenLi-Min ChengWei-Ling LiuXing-Feng ChenYue-Jiao LiYong-Yuan GuanXin ZengYan-Hua Du

Published in: British journal of pharmacology (2022)

]i/SGK1/TGF-β1 signalling pathway. TMEM16A may be a potential new therapeutic target against renal fibrosis.

Keyphrases